{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T17:33:20Z","timestamp":1761154400758,"version":"3.32.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2001,7,1]],"date-time":"2001-07-01T00:00:00Z","timestamp":993945600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2001,7,1]],"date-time":"2001-07-01T00:00:00Z","timestamp":993945600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2001,7]]},"DOI":"10.1136\/ard.60.7.699","type":"journal-article","created":{"date-parts":[[2002,7,27]],"date-time":"2002-07-27T10:45:32Z","timestamp":1027766732000},"page":"699-701","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Severe atherosclerotic changes, including aortic occlusion, associated with hyperhomocysteinaemia and antiphospholipid antibodies"],"prefix":"10.1016","volume":"60","author":[{"given":"P E","family":"Spronk","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E H","family":"Overbosch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N H","family":"Schut","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1136\/ard.60.7.699_bib1","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1001\/archinte.1987.00370050016004","article-title":"Detection, evaluation and treatment of renovascular hypertension.","volume":"147","year":"1987","journal-title":"Arch Int Med"},{"key":"10.1136\/ard.60.7.699_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000173936","article-title":"The spectrum of renovascular hypertension.","volume":"72","author":"Stimpel","year":"1985","journal-title":"Cardiology"},{"key":"10.1136\/ard.60.7.699_bib3","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1136\/ard.49.3.184","article-title":"Renal artery thrombosis and hypertension in a 13 year old girl with antiphospholipid syndrome.","volume":"49","author":"Ostuni","year":"1990","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.60.7.699_bib4","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1136\/ard.50.12.959","article-title":"Management of the antiphospholipid syndrome.","volume":"50","author":"Khamashta","year":"1991","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.60.7.699_bib5","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1136\/ard.51.2.147","article-title":"The antiphospholipid syndrome: a syndrome in evolution.","volume":"51","author":"Asherson","year":"1992","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.60.7.699_bib6","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1097\/00005792-198911000-00004","article-title":"The \u2018primary\u2019 antiphospholipid syndrome: major clinical and serological features.","volume":"68","author":"Asherson","year":"1989","journal-title":"Medicine"},{"key":"10.1136\/ard.60.7.699_bib7","first-page":"740","article-title":"Large vessel occlusion and gangrene in systemic lupus erythematosus and \u2018lupus-like\u2019 disease. A report of six cases.","volume":"13","author":"Asherson","year":"1986","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.60.7.699_bib8","first-page":"1742","article-title":"A \u201cprimary\u201d antiphospholipid syndrome.","volume":"15","author":"Asherson","year":"1988","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.60.7.699_bib9","first-page":"482","article-title":"Primary antiphospholipid syndrome.","volume":"16","author":"Alarc\u00f3n-Segovia","year":"1989","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.60.7.699_bib10","first-page":"390","article-title":"Pathogenetic potential of antiphospholipid antibodies.","volume":"15","author":"Alarc\u00f3n-Segovia","year":"1988","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.60.7.699_bib11","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1055\/s-2007-1001887","article-title":"Antiphospholipid antibodies in coronary artery disease: a review.","volume":"20","author":"Baker","year":"1994","journal-title":"Semin Thromb Hemost"},{"key":"10.1136\/ard.60.7.699_bib12","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1177\/096120339400300503","article-title":"Antiphospholipid antibodies, thrombosis and atherosclerosis in systemic lupus erythematosus: a unifying \u2018membrane stress syndrome\u2019 hypothesis.","volume":"3","author":"Ames","year":"1994","journal-title":"Lupus"},{"key":"10.1136\/ard.60.7.699_bib13","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1006\/clin.1994.1184","article-title":"Atherosclerosis and autoimmunity, short analytical review.","volume":"73","author":"Lopes-Virella","year":"1994","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1136\/ard.60.7.699_bib14","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1177\/000331979504600914","article-title":"Massive lower extremity arterial thrombosis and acute hepatic insufficiency in a young adult with premature atherosclerosis associated with hyperlipoprotein(a)emia and antiphospholipid syndrome.","volume":"46","author":"Levy","year":"1995","journal-title":"Angiology"},{"key":"10.1136\/ard.60.7.699_bib15","first-page":"2394","article-title":"More about the link between thrombosis and atherosclerosis in autoimmune diseases: triglycerides and risk for thrombosis in patients with antiphospholipid antibodies.","volume":"21","author":"Garrido","year":"1994","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.60.7.699_bib16","first-page":"1319","article-title":"The antiphospholipid\/cofactor syndromes.","volume":"23","author":"Alarcon-Segovia","year":"1996","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.60.7.699_bib17","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1046\/j.1365-2249.1997.d01-948.x","article-title":"Involvement of \u03b22 glycoprotein I and anticardiolipin antibodies in oxidatively modified low density lipoprotein uptake by macrophages.","volume":"107","author":"Hasunuma","year":"1997","journal-title":"Clin Exp Immunol"},{"key":"10.1136\/ard.60.7.699_bib18","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1161\/01.CIR.98.11.1108","article-title":"Induction of early atherosclerosis in LDL-receptor-deficient mice immunized with \u03b22-glycoprotein I.","volume":"98","author":"George","year":"1998","journal-title":"Circulation"},{"key":"10.1136\/ard.60.7.699_bib19","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/0140-6736(92)91057-F","article-title":"Antiphospholipid antibodies after myocardial infarction and their relation to mortality, re-infarction, and non-haemorrhagic stroke.","volume":"339","author":"Sletnes","year":"1992","journal-title":"Lancet"},{"key":"10.1136\/ard.60.7.699_bib20","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1159\/000176429","article-title":"Anticardiolipin antibodies in patients with unstable angina.","volume":"84","author":"Diaz","year":"1994","journal-title":"Cardiology"},{"key":"10.1136\/ard.60.7.699_bib21","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/0002-9343(92)90760-9","article-title":"Antiphospholipid antibodies and atherosclerosis.","volume":"92","author":"Lecerf","year":"1992","journal-title":"Am J Med"},{"key":"10.1136\/ard.60.7.699_bib22","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0049-0172(98)80033-4","article-title":"Apoptosis and antiphospholipid antibodies.","volume":"28","author":"Pittoni","year":"1998","journal-title":"Semin Arthritis Rheum"},{"key":"10.1136\/ard.60.7.699_bib23","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1006\/exmp.1999.2243","article-title":"Apoptotic cells as immunogen and antigen in the antiphospholipid syndrome.","volume":"66","author":"Levine","year":"1999","journal-title":"Exp Mol Pathol"},{"key":"10.1136\/ard.60.7.699_bib24","first-page":"34","article-title":"Hyperhomocysteinaemia: a newly recognized risk factor for vascular disease.","volume":"45","author":"Boers","year":"1994","journal-title":"Neth J Med"},{"key":"10.1136\/ard.60.7.699_bib25","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1056\/NEJM199707243370403","article-title":"Plasma homocysteine levels and mortality in patients with coronary artery disease.","volume":"337","author":"Nyg\u00e5rd","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1136\/ard.60.7.699_bib26","first-page":"1737","article-title":"Homocysteine, methylenetetrahydrofolate reductase polymorphism, antiphospholipid antibodies, and thromboembolic events in systemic lupus erythematosus: a retrospective cohort study.","volume":"25","author":"Fijnheer","year":"1998","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.60.7.699_bib27","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1046\/j.1523-1755.1999.00258.x","article-title":"Hyperhomocysteinemia, anticardiolipin antibody status, and risk for vascular access thrombosis in hemodialysis patients.","volume":"55","author":"Manns","year":"1999","journal-title":"Kidney Int"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724442088?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724442088?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard.60.7.699","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T06:00:44Z","timestamp":1736143244000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724442088"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,7]]},"references-count":27,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2001,7]]}},"alternative-id":["S0003496724442088"],"URL":"https:\/\/doi.org\/10.1136\/ard.60.7.699","relation":{},"ISSN":["0003-4967"],"issn-type":[{"type":"print","value":"0003-4967"}],"subject":[],"published":{"date-parts":[[2001,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Severe atherosclerotic changes, including aortic occlusion, associated with hyperhomocysteinaemia and antiphospholipid antibodies","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard.60.7.699","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2001 Annals of the Rheumatic Diseases. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}